COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Partners with the Rodale Institute on Organic and Industrial Hemp Research, Joining Patagonia and Dr. Bronner’s

16/10/2018 - 14:45

LAS VEGAS, Oct. 16, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OCTQB: CVSI) preeminent supplier and manufacturer of industry leading hemp extract brand, PlusCBD Oil™ , announces that the Company is now sponsoring [...]

Cannabix Technologies Comments on Legalization of Marijuana in Canada, Impaired Driving and Workplace Safety

16/10/2018 - 14:45

The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]

Zosano Appoints New Chief Financial Officer

16/10/2018 - 14:30

Seasoned financial and operational executive further strengthens management team FREMONT, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage [...]

Sharps Compliance Announces First Quarter Fiscal 2019 Conference Call and Webcast

16/10/2018 - 14:30

HOUSTON, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its first quarter 2019 results for the period ended September 30, 2018, before the opening of the [...]

Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap Research

16/10/2018 - 14:30

JUPITER, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Biomerica Reports 1st Quarter Fiscal 2019 Financials

16/10/2018 - 14:30

Irvine, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,272,870 for the three months ending August 31, 2018, compared to $1,444,483 for the same period in the [...]

North Bud Farms Provides a Corporate Update

16/10/2018 - 14:30

TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) ("NORTHBUD" or the "Company") is pleased to provide shareholders an update on our corporate activities. Construction of Our Cannabis Production [...]

Maple Leaf Accepts Loan Offer from Silver Arch Capital Partners

16/10/2018 - 14:30

CALGARY, Alberta, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) has accepted a loan offer from Silver Arch Capital Partners (the “ Lender [...]

Two new Board of Director appointments to liquid biopsy company Clinical Genomics

16/10/2018 - 14:30

BRIDGEWATER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to the company’s Board of Directors: [...]

Breathtec to Complete Share Consolidation

16/10/2018 - 14:22

VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “ Company ”) is pleased to announce that further to its news release [...]

CRUZANI to Acquire Vitamin Infused Water Beverage Company as First Step to Entering New Infused Products Market

16/10/2018 - 14:15

ATLANTA, Oct. 16, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI), a business development company focused on creating and acquiring global franchise concepts, along with peripheral food-related businesses, is [...]

Radient Technologies and Grupo Natac announce JV to form Natac Solutions

16/10/2018 - 14:08

EDMONTON, Alberta and MADRID, Spain, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Company”) (TSX Venture: RTI), to support its ongoing health and wellness activities, is pleased to [...]

Athenex to Present Positive Data of Oraxol Clinical Trial in Breast Cancer at the ESMO 2018 Congress

16/10/2018 - 14:07

BUFFALO, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

16/10/2018 - 14:05

External manufacturing agreement reached to enable production of clinical trial materials for SB204 and the acne indication, with the potential to include additional product candidates Extension of capacity complements [...]

SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of Rheumatoid Arthritis

16/10/2018 - 14:01

Proprietary Device Delivers Doses of Electricity to Activate Systemic Anti-inflammatory Response Data Readout Expected in Q1 2019 VALENCIA, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage [...]

C-RAD Web Presentation Interim Report Q3 2018

16/10/2018 - 14:00

Presentation of the report for the first three quarters of the fiscal year 2018: Date: Friday October 26, 2018 / kl. 13:00 CEST Venue: Online Presentation Topic: C-RAD Interim Report Q3 2018 Procedure: Please register [...]

Matinas BioPharma to Present at the 8th Annual Partnership Opportunities in Drug Delivery Conference

16/10/2018 - 14:00

BEDMINSTER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, announced today that Raphael Mannino, Ph.D., Chief Scientific Officer [...]

Selecta Biosciences to Present New Five Monthly Dose Phase 2 Data for SEL-212 in Chronic, Severe Gout at Upcoming 2018 ACR Annual Meeting

16/10/2018 - 14:00

Data continue to suggest sustained serum uric acid (sUA) level reductions and low number of flares over five months of treatment Results correlated with low or no anti-drug antibodies (ADAs) against the pegsiticase [...]

Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors

16/10/2018 - 14:00

NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]